Nutrição e Câncer de Mama – Artigo 7
High-dose vitamin C suppresses the invasion and metastasis of breast cancer cells via inhibiting
epithelial-mesenchymal transition
Purpose: Vitamin C (VC) is a kind of essential nutrient in the body regarded as a canonical antioxidant during the past hundred years. However, the anti-cancer effect of VC is controversial. Our study is trying to clarify the relationship between VC dosage and breast cancer metastasis.
Methods: Human breast cancer cell lines Bcap37 and MDA-MB-453 were treated with VC at three different concentrations (low-dose, 0.01 mM; medium-dose, 0.1 mM; high-dose, 2 ...
Nutrição e Câncer de Mama – Artigo 6
Global Nutrition Research: Nutrition and Breast Cancer Prevention as a Model
Abstract
The gene-environment interaction is paramount in light of the worldwide rise of incidence of chronic diseases, with cancers in the pole position. Diet is an environmental factor with potential to influence cancer onset by shaping the epigenome (i.e., the genome organization that controls the differential expression of genes). Yet, there is no consensus regarding how diet might help prevent breast cancer, the second most frequent malignancy globally. We propose that the complexity of breast cancers ...
Nutrição e Câncer de Mama – Artigo 5
Epidermal growth factor receptor (EGFR) gene alteration and protein overexpression in Malaysian
triple-negative breast cancer (TNBC) cohort
Background: Epidermal growth factor receptor (EGFR) is a member of the ErbB family of tyrosine kinase receptor proteins that plays important roles in tumour cell survival and proliferation. EGFR has been reported to be overexpressed in up to 78% of triple-negative breast cancer (TNBC) cases suggesting it as a potential therapeutic target. The clinical trials of anti-EGFR agents in breast cancer showed low response rates. However, a subgroup ...
Nutrição e Câncer de Mama – Artigo 4
Dietary Natural Products for Prevention and Treatment of Breast Cancer
Abstract: Breast cancer is the most common cancer among females worldwide. Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer. Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer, such as soy, pomegranate, mangosteen, citrus fruits, apple, grape, mango, cruciferous vegetables, ginger, garlic, black cumin, edible macro-fungi, and ...
Nutrição e Câncer de Mama – Artigo 3
Bioelectric Impedance Vector Analysis (BIVA) in Breast Cancer Patients: A Tool for Research and
Clinical Practice
Abstract: Background and objectives: Body composition assessment can provide information associated with breast cancer patients’ (BCP) prognosis, that can lead interventions to improve survival outcomes. The aim of this study was to evaluate the effect of an individualized nutrition intervention program on breast cancer patients using bioelectrical impedance vector analysis (BIVA). Materials and Methods: This is a pretest-posttest study in recently diagnosed nonmetast...
Nutrição e Câncer de Mama – Artigo 2
Associations between Dietary Acid Load and Biomarkers of Inflammation and Hyperglycemia in
Breast Cancer Survivors
Abstract: Metabolic acidosis can lead to inflammation, tissue damage, and cancer metastasis. Dietary acid load contributes to metabolic acidosis if endogenous acid–base balance is not properly regulated. Breast cancer survivors have reduced capacities to adjust their acid–base balance; yet, the associations between dietary acid load and inflammation and hyperglycemia have not been examined among them. We analyzed data collected from 3042 breast cancer survivors ...
Nutrição e Câncer de Mama – Artigo 1
Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized
Pilot Study
Abstract: This study analyzes an oral supplement of molecular iodine (I2), alone and in combination with the neoadjuvant therapy 5-fluorouracil/epirubicin/cyclophosphamide or taxotere/epirubicin (FEC/TE) in women with Early (stage II) and Advanced (stage III) breast cancer. In the Early group, 30 women were treated with I2 (5 mg/day) or placebo (colored water) for 7–35 days before surgery. For the Advanced group, 30 patients received I2 or placebo, along with FEC/TE treatmen...
